Oncothermia is the next generation medical innovation that delivers selective, controlled and deep energy for cancer treatment. The basic principles for oncothermia stem from oncological hyperthermia, the oldest approach to treating cancer. Nevertheless, hyperthermia has been wrought with significant controversy, mostly stemming from shortcomings of controlled energy delivery. Oncothermia has been able to overcome these insufficiencies and prove to be a controlled, safe and efficacious treatment option. This book is the first attempt to elucidate the theory and practice of oncothermia, based on rigorous mathematical and biophysical analysis, not centered on the temperature increase. It is supported by numerous in-vitro and in-vivo findings and twenty years of clinical experience. This book will help scientists, researchers and medical practitioners in understanding the scientific and conceptual underpinnings of oncothermia and will add another valuable tool in the fight against cancer. Professor Andras Szasz is the inventor of oncothermia and the Head of St Istvan University's Biotechnics Department in Hungary. He has published over 300 papers and lectured at various universities around the world. Dr. Oliver Szasz is the managing director of Oncotherm, the global manufacturer and distributor of medical devices for cancer treatment used in Europe & Asia since the late 1980s. Dr. Nora Szasz is currently a management consultant in healthcare for McKinsey & Co.

The next generation of oncological hyperthermia involves the medical innovation of selectively heating up the malignant cells of the body in a controlled way. The easily-distinguishable biophysical and physiological characteristics of cancer cells and their immediate environment are the focus of the targeted energy delivery of this treatment. This heterogenic heating concept breaks with the homogeneous nature of conventional hyperthermia, where an isothermally equal temperature is applied to the large surface area of a solid tumor. Due to its selectivity, the new concept enables the usage of a significantly lower energy, making it safer, less toxic, and easier to use. This book shows the challenges facing oncological hyperthermia, and highlights clinical results obtained in various countries. It also presents discussions about the theoretical basis of the method, adding some technical discussions and clarifying the most difficult points of its design. The contributions dealing with clinical results use state-of-art conventional therapies with complementary hyperthermia and show the advantages of such a combination.

*As Seen on Chris Beat Cancer A groundbreaking, comprehensive guide on managing, treating, and preventing cancer. *Introducing: The Holistic Model of the Twelve Vital Fields* It’s a sad truth of our times that one in three people will experience cancer in their lifetime. By 2040, the probability will rise to one in two. As a comprehensive guide on natural treatment, Holistic Cancer Medicine is essential reading for every cancer patient—from newly diagnosed to late stage. For those seeking to prevent the disease, it also provides key information on how to reduce your risks. As the founder and director of Germany’s leading complementary cancer clinic, Dr. Henning Saupe offers Holistic Cancer Medicine as the culmination of twenty-five years of experience treating the disease. Dr. Saupe’s unique vantage and insight complements standard treatment models with less burdensome, less invasive, and more natural methods. His program focuses on how those affected by cancer can carry out treatment to cure or control the disease while maintaining a high quality of life. Other topics include: The revolutionary Holistic Model of the Twelve Vital Fields The dynamic interplay between nutrition, circulation, the microbiome, mitochondrial health, acid-base balance, and chronic infections, and more Specific tumor-killing methods, such as insulin potentiation therapy (IPT), photodynamic therapy (PDT), local and whole-body hyperthermia, and pulsating electromagnetic frequency therapy (PEMF) Inner-life training (ILT) and affirmations for both physical and emotional pain Tools for those accompanying relatives, friends, or colleagues through the stages of cancer And much more Holistic Cancer Medicine is a groundbreaking book for a critical time of life with an essential and compassionate message: that a diagnosis of cancer and living a vibrant life are not mutually exclusive.

The book "Hyperthermia", published by InTech, and edited by Dr. Nagraj Huilgol, of the Department of Radiation Oncology, Dr. Balabhai Nanavati Hospital, India, is comprised of 8 Open Access chapters, covering a wide range of Hyperthermia-related scientific research.

Volume I.C An outbreak of a respiratory disease first reported in Wuhan, China in December 2019 and the causative agent was discovered in January 2020 to be a novel betacoronovirus of the same subgenus as SARS-CoV and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) has rapidly disseminated worldwide, with clinical manifestations ranging from mild respiratory symptoms to severe pneumonia and a fatality rate estimated around 2%. Person to person transmission is occurring both in the community and healthcare settings. The World Health Organization (WHO) has recently declared the COVID-19 epidemic a public health emergency of international concern. The ongoing outbreak presents many clinical and public health management challenges due to limited understanding of viral pathogenesis, risk factors for infection, natural history of disease including clinical presentation and outcomes, prognostic factors for severe illness, period of infectivity, modes and extent of virus inter-human transmission, as well as effective preventive measures and public health response and containment interventions. There are no antiviral treatment nor vaccine available but fast track research and development efforts including clinical therapeutic trials are ongoing across the world. Managing this serious epidemic requires the appropriate deployment of limited human resources across all cadres of health care and public health staff, including clinical, laboratory, managerial and epidemiological data analysis and risk assessment experts. It presents challenges around public communication and messaging around risk, with the potential for misinformation and disinformation. Therefore, integrated operational research and intervention, learning from experiences across different fields and settings should contribute towards better understanding and managing COVID-19. This Research Topic aims to highlight interdisciplinary research approaches deployed during the COVID-19 epidemic, addressing knowledge gaps and generating evidence for its improved management and control. It will incorporate critical, theoretically informed and empirically grounded original research contributions using diverse approaches, experimental, observational and intervention studies, conceptual framing, expert opinions and reviews from across the world. The Research Topic proposes a multi-dimensional approach to improving the management of COVID-19 with scientific contributions from all areas of virology, immunology, clinical microbiology, epidemiology, therapeutics, communications as well as infection prevention and public health risk assessment and management studies.